Statera Biopharma
Earnings Date & Report
Last updated:
Statera Biopharma’s last earnings date was on 29 Mar 2023.
Statera Biopharma stock Earnings report, Estimates & History
| 2021-08-16 | -0.15302 | -0.26895 |
|---|---|---|
| 2021-11-15 | -0.47 | -0.47 |
| 2022-03-31 | -0.89708 | -2.40238 |
| 2022-08-15 | -0.02824 | -0.08297 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Statera Biopharma stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 29 Mar 2023 | N/A | N/A | N/A | N/A | N/A | |
| 13 Feb 2023 | N/A | N/A | N/A | N/A | N/A | |
| 2 Jan 2023 | N/A | N/A | N/A | N/A | N/A | |
| 15 Aug 2022 | Missed | -$0.03 | -$0.08 | 3.92M | 768.82K | |
| 31 Mar 2022 | Missed | -$0.9 | -$2.4 | 59.41M | 1.25M | |
| 15 Nov 2021 | Matched | -$0.47 | -$0.47 | 6.25M | 236.51K | Earnings Call Transcript |
| 16 Aug 2021 | Missed | -$0.15 | -$0.27 | 2.26M | N/A | |
Statera Biopharma Earnings report FAQs
When is Statera Biopharma's next Earnings date?
The company has not set the next earnings date yet. The latest Statera Biopharma's earnings date was on 31 Mar 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.